A "Knife Fight" with the FDA: The Trump White House's Relentless Attacks on FDA's Coronavirus Response

Loading...
Thumbnail Image
Serial Number
Levin Center Identifier
Document Date
2022-08-24
Report Length
69 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Found Using Methodology
Yes
Commission(s)
Idependent Author(s)
Brief Executive Summary
This report from the Select Subcommittee on the Coronavirus Crisis of the House Committee on Oversight and Reform is the second installment of findings from its investigation into the federal government's coronavirus pandemic response. The report focuses on three instances where Trump White House officials exerted coordinated pressure on the Food and Drug Administration (FDA) to align with political objectives. The report states the instances involve efforts to reauthorize hydroxychloroquine despite its ineffectiveness and potential danger, influence FDA's messaging on convalescent plasma before the 2020 Republican National Convention, and delay FDA guidance on coronavirus vaccine authorizations for political reasons.
Press Releases and Contextual Information
Related Hearings
House Committee on Oversight and Reform, Select Subcommittee on the Coronavirus Crisis, hearing on "The Urgent Need for a National Plan to Contain the Coronavirus," 116th Cong., (2020, July 31)
Senate Committee on Homeland Security and Governmental Affairs, hearing on "Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Parts I-II," 116th Cong., (2020, November 19 and December 8)
House Committee on Oversight and Reform, Select Subcommittee on the Coronavirus Crisis, hearing on "Trump White House Coronavirus Response Coordinator Dr. Deborah Birx," 117th Cong., (2022, June 23)
Senate Committee on Health, Education, Labor, and Pensions, hearing on "COVID-19: An Update on the Federal Response," 116th Cong., (2020, September 23)
House Committee on Oversight and Reform, Select Subcommittee on the Coronavirus Crisis, hearing on "Combating Coronavirus Cons and the Monetization of Misinformation," 117th Cong., (2021, November 17)
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views
Citation